Moderna

MODERNA (MRNA): WALLSTREET THREW IT OUT - I’LL PICK IT UP AND CASH THE CHECK

woodworthfund

Invested

Community Contributor

Published

30 Apr 25

Updated

01 May 25

woodworthfund's Fair Value

US$175.00

85.6% undervalued

02 May

US$25.14

-65.5%

4.4%

-65.5%

4.4%

Edit anytime before May 14 2:38 AM. Then post Updates to your followers.

Author's Valuation

US$175.0

85.6% undervalued

woodworthfund's Fair Value

Narrative

Updates1

Shared on01 May 25

woodworthfund made no meaningful changes to valuation assumptions.

woodworthfund'sFair Value

US$175.0

85.6% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

19.53%

Biotech revenue growth rate

7.45%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.80%

Calculation

US$3.44b

Earnings '29

28.27x

PE Ratio '29

US$97.23b

Market Cap '29

US$97.23b

Market Cap '29

405.09m

No. shares '29

US$240.01

Share Price '29

US$240.01 Share Price '29

Discounted to 2024 @ 6.52% p.a.

US$175.01

Fair Value '24